Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3

T follicular helper (Tfh) cells are essential providers of help to B cells. The transcription factor B-cell CLL/lymphoma 6 (Bcl6) is a lineage-defining regulator of Tfh cells and germinal center B cells. In B cells, Bcl6 has the potential to recruit distinct transcriptional corepressors through its...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 112; no. 43; pp. 13324 - 13329
Main Authors Nance, J. Philip, Bélanger, Simon, Johnston, Robert J., Hu, Joyce K., Takemori, Toshitada, Crotty, Shane
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 27.10.2015
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:T follicular helper (Tfh) cells are essential providers of help to B cells. The transcription factor B-cell CLL/lymphoma 6 (Bcl6) is a lineage-defining regulator of Tfh cells and germinal center B cells. In B cells, Bcl6 has the potential to recruit distinct transcriptional corepressors through its BTB domain or its poorly characterized middle domain (also known as RDII), but in Tfh cells the roles of the Bcl6 middle domain have yet to be clarified. Mimicked acetylation of the Bcl6 middle domain (K379Q) in CD4 T cells results in significant reductions in Tfh differentiation in vivo. Blimp1 (Prdm1) is a potent inhibitor of Tfh cell differentiation. Although Bcl6 K379Q still bound to thePrdm1 cis-regulatory elements in Tfh cells,Prdm1expression was derepressed. This was a result of the failure of Bcl6 K379Q to recruit metastasis-associated protein 3 (MTA3). The loss of Bcl6 function in Bcl6 K379Q-expressing CD4 T cells could be partially rescued by abrogatingPrdm1expression. In addition toPrdm1, we found that Bcl6 recruits MTA3 to multiple genes involved in Tfh cell biology, including genes important for cell migration, cell survival, and alternative differentiation pathways. Thus, Bcl6 middle domain mediated repression is a major mechanism of action by which Bcl6 controls CD4 T-cell fate and function.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by Rafi Ahmed, Emory University, Atlanta, GA, and approved September 16, 2015 (received for review April 15, 2015)
Author contributions: J.P.N. and S.C. designed research; J.P.N., S.B., R.J.J., and J.K.H. performed research; R.J.J. and T.T. contributed new reagents/analytic tools; J.P.N., S.B., J.K.H., and S.C. analyzed data; and J.P.N., S.B., and S.C. wrote the paper.
1Present address: Department of Immuno-Oncology Discovery, Bristol-Myers Squibb, Redwood City, CA 94063.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1507312112